These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

479 related articles for article (PubMed ID: 24981557)

  • 1. Variation in long-term antipsychotic polypharmacy and high-dose prescribing across physicians and hospitals.
    Latimer EA; Naidu A; Moodie EE; Clark RE; Malla AK; Tamblyn R; Wynant W
    Psychiatr Serv; 2014 Oct; 65(10):1210-7. PubMed ID: 24981557
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Best practices: An initiative to curtail the use of antipsychotic polypharmacy in a state psychiatric hospital.
    Patrick V; Schleifer SJ; Nurenberg JR; Gill KJ
    Psychiatr Serv; 2006 Jan; 57(1):21-3. PubMed ID: 16399958
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Patient, Physician and Organizational Influences on Variation in Antipsychotic Prescribing Behavior.
    Tang Y; Chang CC; Lave JR; Gellad WF; Huskamp HA; Donohue JM
    J Ment Health Policy Econ; 2016 Mar; 19(1):45-59. PubMed ID: 27084793
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Exposure to potentially dangerous drug-drug interactions involving antipsychotics.
    Guo JJ; Wu J; Kelton CM; Jing Y; Fan H; Keck PE; Patel NC
    Psychiatr Serv; 2012 Nov; 63(11):1080-8. PubMed ID: 22910806
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Medical decision making in antipsychotic drug choice for schizophrenia.
    Hamann J; Langer B; Leucht S; Busch R; Kissling W
    Am J Psychiatry; 2004 Jul; 161(7):1301-4. PubMed ID: 15229068
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The hidden magnitude of polypharmacy: using defined daily doses and maximum licensed daily doses to measure antipsychotic load.
    Nguyen ML; Sunderland B; Lim S; Hattingh L; Chalmers L
    Int J Clin Pharm; 2019 Dec; 41(6):1642-1651. PubMed ID: 31677120
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevalence, trends, and factors associated with antipsychotic polypharmacy among Medicaid-eligible schizophrenia patients, 1998-2000.
    Ganguly R; Kotzan JA; Miller LS; Kennedy K; Martin BC
    J Clin Psychiatry; 2004 Oct; 65(10):1377-88. PubMed ID: 15491242
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of patients' preexisting metabolic risk factors on the choice of antipsychotics by office-based physicians.
    Li C; Mittal D; Owen RR
    Psychiatr Serv; 2011 Dec; 62(12):1477-84. PubMed ID: 22193796
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prescription practices in the treatment of agitation in newly hospitalized Chinese schizophrenia patients: data from a non-interventional naturalistic study.
    Zhang SZ; Mu YG; Liu Q; Shi Y; Guo LH; Li LZ; Yang FD; Wang Y; Li T; Mei QY; He HB; Chen ZY; Su ZH; Liu TB; Xie SP; Tan QR; Zhang JB; Zhang CP; Sang H; Mi WF; Zhang HY
    BMC Psychiatry; 2019 Jul; 19(1):216. PubMed ID: 31291931
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Psychotropic prescribing in seriously violent men with schizophrenia or personality disorder in a UK high security hospital.
    Stone-Brown K; Naji M; Francioni A; Myers K; Samarendra H; Mushtaq-Chaudhry H; Heslop S; Sengupta S; Ross CC; Larkin F; Das M
    CNS Spectr; 2016 Feb; 21(1):60-9. PubMed ID: 26726766
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of Concurrent Oral and Long-Acting Injectable Antipsychotic Prescribing at the Minneapolis Veterans Affairs Health Care System.
    Dimitropoulos E; Drogemuller L; Wong K
    J Clin Psychopharmacol; 2017 Oct; 37(5):605-608. PubMed ID: 28816923
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antipsychotic polypharmacy and high-dose prescription in schizophrenia: a 5-year comparison.
    Roh D; Chang JG; Kim CH; Cho HS; An SK; Jung YC
    Aust N Z J Psychiatry; 2014 Jan; 48(1):52-60. PubMed ID: 23671214
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Underprescribing of clozapine and unexplained variation in use across hospitals and regions in the Canadian province of Québec.
    Latimer E; Wynant W; Clark R; Malla A; Moodie E; Tamblyn R; Naidu A
    Clin Schizophr Relat Psychoses; 2013 Apr; 7(1):33-41. PubMed ID: 23367500
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dosage patterns of antipsychotic drugs for the treatment of schizophrenia in Swedish ambulatory clinical practice--a highly individualized therapy.
    Bingefors K; Isacson D; Lindström E
    Nord J Psychiatry; 2003; 57(4):263-9. PubMed ID: 12888400
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Maintenance phase treatment of psychotic disorders in outpatients from Serbia - focus on long-term benzodiazepine use.
    Marić NP; Andrić Petrović S; Jerotić S; Ristić I; Savić B; Zebić M; Vuković V; Britvić D; Golubović O; Jakšić M; Jevđić K; Kolašinac Z; Lalović N; Mirković Ilić J; Nikolić S; Paunović Č; Pavlović Z; Pejović Nikolić S; Perović V; Popović J; Ranđić Avakumović V; Stojanović S; Tatarević M; Živković I; Voskresenski T; Jovanović N
    Int J Psychiatry Clin Pract; 2020 Sep; 24(3):315-321. PubMed ID: 32459564
    [No Abstract]   [Full Text] [Related]  

  • 16. Patterns of antipsychotic and anticholinergic prescribing for hospital inpatients.
    Paton C; Lelliott P; Harrington M; Okocha C; Sensky T; Duffett R
    J Psychopharmacol; 2003 Jun; 17(2):223-9. PubMed ID: 12870571
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prescribing of Clozapine and Antipsychotic Polypharmacy for Schizophrenia in a Large Medicaid Program.
    Tang Y; Horvitz-Lennon M; Gellad WF; Lave JR; Chang CH; Normand SL; Donohue JM
    Psychiatr Serv; 2017 Jun; 68(6):579-586. PubMed ID: 28196460
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of pharmacist intervention on physician prescribing in patients with chronic schizophrenia: a descriptive pre/post study.
    Hashimoto Y; Tensho M
    BMC Health Serv Res; 2016 Apr; 16():150. PubMed ID: 27117589
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antipsychotic prescribing quality and ethnicity: a study of hospitalized patients in south east London.
    Connolly A; Rogers P; Taylor D
    J Psychopharmacol; 2007 Mar; 21(2):191-7. PubMed ID: 17329299
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antipsychotic prescribing for vulnerable populations: a clinical audit at an acute Australian mental health unit at two-time points.
    McMillan SS; Jacobs S; Wilson L; Theodoros T; Robinson G; Anderson C; Mihala G; Wheeler AJ
    BMC Psychiatry; 2017 Apr; 17(1):139. PubMed ID: 28407747
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.